Cargando…
Treatment and prevention of cancer-associated thrombosis in the Netherlands: A national survey
BACKGROUND: In the recent years, numerous studies on the optimal treatment and prevention of cancer-associated venous thromboembolism (VTE) have been published, leading to updated (inter)national guidelines. These include direct oral anticoagulants (DOACs) as the first-line treatment agent in genera...
Autores principales: | Kaptein, Fleur H.J., Guman, Noori A.M., van Es, Nick, Kamphuisen, Pieter W., Klok, Frederikus A., Mairuhu, Albert T.A., Huisman, Menno V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943872/ https://www.ncbi.nlm.nih.gov/pubmed/36846646 http://dx.doi.org/10.1016/j.rpth.2023.100057 |
Ejemplares similares
-
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
por: Huisman, Menno V., et al.
Publicado: (2022) -
Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
por: Hendriks, Stephan V., et al.
Publicado: (2020) -
Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
por: Klok, Frederikus A., et al.
Publicado: (2019) -
Pharmacological properties of betrixaban
por: Huisman, Menno V, et al.
Publicado: (2018) -
First do no harm
por: Huisman, Menno V., et al.
Publicado: (2022)